Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Vultaggio

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
Biomedicines|February 27, 2026
Immunogenicity in Fabry Disease: Current Issues, Coping Strategies, and Future DirectionsAndrea Matucci, Sandro Feriozzi, Elena Biagini, et al.
The Journal of Allergy and Clinical Immunology. Global|August 20, 2025
Consensus from European experts on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: Results from the OverSEA Delphi studyClaus Bachert, Guy Brusselle, José Antonio Castillo Vizuete, et al.
Pulmonary Pharmacology & Therapeutics|October 5, 2014
Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in ItalyFederica Novelli, Manuela Latorre, Letizia Vergura, et al.
Microbes and Infection|February 6, 2008
T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasisAlessandra Vultaggio, Letizia Lombardelli, Maria Grazia Giudizi, et al.
Immunology|May 2, 2015
Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammationFrancesca Nencini, Sara Pratesi, Giulia Petroni, et al.
Gynecologic Oncology Reports|December 20, 2021
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancerAlessandra Vultaggio, Maria Cristina Petrella, Federica Tomao, et al.
Panminerva Medica|July 9, 2021
Can selective serotonin reuptake inhibitors/serotonin and norepinephrine reuptake inhibitor antidepressants decrease the "cytokine storm" in the course of COVID-19 pneumonia?Leonardo Fei, Gabriele Santarelli, Giulio D'Anna, et al.
Respiration; International Review of Thoracic Diseases|March 10, 2025
Asthma Phenotype Can Be Influenced by Recurrent Respiratory Infections in Patients with Primary Antibody Deficiency: The Impact of Ig TherapyEmanuele Vivarelli, Margherita Perlato, Matteo Accinno, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2006
Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN releaseLucia Filì, Simona Ferri, Francesco Guarna, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 7, 2025
Urinary rituximab loss and rate of treatment failure in membranous nephropathyMarco Allinovi, Matteo Accinno, Cecilia Finocchi, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Biomedicines|February 27, 2026
Immunogenicity in Fabry Disease: Current Issues, Coping Strategies, and Future DirectionsAndrea Matucci, Sandro Feriozzi, Elena Biagini, et al.
The Journal of Allergy and Clinical Immunology. Global|August 20, 2025
Consensus from European experts on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: Results from the OverSEA Delphi studyClaus Bachert, Guy Brusselle, José Antonio Castillo Vizuete, et al.
Pulmonary Pharmacology & Therapeutics|October 5, 2014
Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in ItalyFederica Novelli, Manuela Latorre, Letizia Vergura, et al.
Microbes and Infection|February 6, 2008
T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasisAlessandra Vultaggio, Letizia Lombardelli, Maria Grazia Giudizi, et al.
Immunology|May 2, 2015
Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammationFrancesca Nencini, Sara Pratesi, Giulia Petroni, et al.
Gynecologic Oncology Reports|December 20, 2021
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancerAlessandra Vultaggio, Maria Cristina Petrella, Federica Tomao, et al.
Panminerva Medica|July 9, 2021
Can selective serotonin reuptake inhibitors/serotonin and norepinephrine reuptake inhibitor antidepressants decrease the "cytokine storm" in the course of COVID-19 pneumonia?Leonardo Fei, Gabriele Santarelli, Giulio D'Anna, et al.
Respiration; International Review of Thoracic Diseases|March 10, 2025
Asthma Phenotype Can Be Influenced by Recurrent Respiratory Infections in Patients with Primary Antibody Deficiency: The Impact of Ig TherapyEmanuele Vivarelli, Margherita Perlato, Matteo Accinno, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2006
Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN releaseLucia Filì, Simona Ferri, Francesco Guarna, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 7, 2025
Urinary rituximab loss and rate of treatment failure in membranous nephropathyMarco Allinovi, Matteo Accinno, Cecilia Finocchi, et al.
Pageof 14